NALFD/NASH

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.
Alan Bonder, MD—Hepatic Diseases Section Editor for Gastroenterology Learning Network—is joined by Gordon Jiang, MD, and Hirsh Trivedi, MD, from Beth Israel Deaconess Medical Center and Harvard Medical School to talk about diagnosing and managing fatty liver disease in both the primary care setting and the hepatology practice.
In this podcast, Jonathan Stine, MD, from the the Milton S. Hershey Medical Center of Pennsylvania State University, discusses his proof-of-concept study on the effects of exercise on gut dysbiosis and fatty liver disease.
Researchers conducted a study of genomic data to clarify the relationships among nonalcoholic fatty liver disease, type 2 diabetes, and obesity. Lead author Wanqing Liu, PhD, answered our questions about the study.
Arun Sanyal, MD, from Virginia Commonwealth University, talks about how to make progress in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD.
He discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD.
He discusses his session titled “The Microbiome and Fatty Liver Disease,” which he presented at Harvard’s Nonalcoholic Fatty Liver Disease (NAFLD): Mechanisms and Novel Therapeutics symposium.
He talks about the treatment options that are available for treating nonalcoholic fatty liver disease via metabolic pathways. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD.
He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD.
Erica Monrose, MD, and Tatyana Kushner, MD, from the Icahn School of Medicine at Mount Sinai, explain the association between nonalcoholic fatty liver disease and intrahepatic cholestasis of pregnancy, diagnosing and treating NAFLD and intrahepatic cholestatis during pregnancy, and counseling your patients.
Manal Abdelmalek, MD, MPH, from Duke University, answers our questions about the challenges in the diagnosis and staging of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Dr Harrison discusses key takeaways for gastroenterologists and hepatologists about the management of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.